StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3039% above fair value
$610.54−23.44 (-3.70%)

Close on Nov 20, 2026Market cap $17.08BP/E 33.9Yield –

Medpace net income

Net income is the profit left for shareholders after every expense, interest and tax.

Medpace's net income for the twelve months ending Sep 30, 2026 was $517.83M, up 19.6% year over year. For fiscal 2025 it was $451.12M, up 11.6% from the year before. The highest annual figure on record is $451.12M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$451.12M+11.6%
FY2024Dec 31, 2024$404.39M+43.0%
FY2023Dec 31, 2023$282.81M+15.3%
FY2022Dec 31, 2022$245.37M+34.9%
FY2021Dec 31, 2021$181.85M+25.1%
FY2020Dec 31, 2020$145.38M+44.7%
FY2019Dec 31, 2019$100.44M+37.2%
FY2018Dec 31, 2018$73.19M+87.1%
FY2017Dec 31, 2017$39.12M+191.4%
FY2016Dec 31, 2016$13.43M–
FY2015Dec 31, 2015-$8.67M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$137.46M+23.7%
Q2 FY2026Jun 30, 2026$121.36M+34.5%
Q1 FY2026Mar 31, 2026$123.87M+8.1%
Q4 FY2025Dec 31, 2025$135.13M+15.5%
Q3 FY2025Sep 30, 2025$111.14M+15.3%
Q2 FY2025Jun 30, 2025$90.26M+2.2%
Q1 FY2025Mar 31, 2025$114.60M+11.7%
Q4 FY2024Dec 31, 2024$117.02M+49.5%
Q3 FY2024Sep 30, 2024$96.43M+36.7%
Q2 FY2024Jun 30, 2024$88.35M+44.7%
Q1 FY2024Mar 31, 2024$102.59M+40.7%
Q4 FY2023Dec 31, 2023$78.30M+14.0%
Q3 FY2023Sep 30, 2023$70.55M+6.9%
Q2 FY2023Jun 30, 2023$61.07M+23.7%
Q1 FY2023Mar 31, 2023$72.89M+18.9%
Q4 FY2022Dec 31, 2022$68.67M+37.2%
Q3 FY2022Sep 30, 2022$66.03M+35.9%
Q2 FY2022Jun 30, 2022$49.36M+23.6%
Q1 FY2022Mar 31, 2022$61.31M+41.6%
Q4 FY2021Dec 31, 2021$50.03M-1.6%
Q3 FY2021Sep 30, 2021$48.57M+17.2%
Q2 FY2021Jun 30, 2021$39.93M+65.7%
Q1 FY2021Mar 31, 2021$43.31M+49.6%
Q4 FY2020Dec 31, 2020$50.87M+70.6%
Q3 FY2020Sep 30, 2020$41.46M+72.9%
Q2 FY2020Jun 30, 2020$24.10M-12.2%
Q1 FY2020Mar 31, 2020$28.95M+50.8%
Q4 FY2019Dec 31, 2019$29.81M+31.0%
Q3 FY2019Sep 30, 2019$23.98M+24.2%
Q2 FY2019Jun 30, 2019$27.46M+65.7%
Q1 FY2019Mar 31, 2019$19.20M+31.9%
Q4 FY2018Dec 31, 2018$22.76M+101.6%
Q3 FY2018Sep 30, 2018$19.31M+96.4%
Q2 FY2018Jun 30, 2018$16.57M+73.4%
Q1 FY2018Mar 31, 2018$14.55M+72.3%
Q4 FY2017Dec 31, 2017$11.29M–
Q3 FY2017Sep 30, 2017$9.83M–
Q2 FY2017Jun 30, 2017$9.55M–
Q1 FY2017Mar 31, 2017$8.45M–
Q4 FY2016Dec 31, 2016-$21.00K–

More Medpace figures

See a number that looks wrong?